Source: International Congress 2015 – New insights into exercise and muscle performance
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Ramon Langen (Maastricht, Netherlands), Ramon Langen, Nicky Pansters, Marco Kelders, Chiel De Theije, Annemie Schols. Inactivation of glycogen synthase kinase-3 is not required for recovery of muscle mass of disuse-atrophied muscle. Eur Respir J 2015; 46: Suppl. 59, 4606

Member's Comments

No comment yet.

Related content which might interest you: Inactivation of glycogen synthase kinase 3β (GSK-3β) enhances skeletal muscle oxidative metabolism Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD Year: 2015 Skeletal muscle atrophy caused by acute pulmonary inflammation is dependent on a glycogen synthase kinase-3beta - glucocorticoid receptor signaling axis Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey Year: 2015 Hypoxia sensitizes skeletal muscle to fasting-induced muscle atrophy; role of AMPK activation Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015 Muscle morphology, metabolism and muscle function: general principles Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=86 Year: 2003 TNF-α-induced NF-κB activation stimulates skeletal muscle glycolytic metabolism through activation of HIF-1α Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Hypoxia-induced muscle atrophy and impaired regulation of protein turnover are partially dependent on muscle glucocorticoid receptor signaling Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 GSK-3β is required for the induction of skeletal muscle atrophy Source: Annual Congress 2010 - Distortions of the respiratory system in the lung function Year: 2010 Parallel activation of autophagy and myogenesis during muscle mass recovery following disuse-atrophy Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Pectoralis muscle area and skeletal muscle strength in patients with ILD Source: International Congress 2016 – From cardiopulmonary interaction to locomotor muscles and dyspnoea in health and disease Year: 2016 Features of skeletal muscle dysfunction in COPD patients with obesity Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Hypoxia signaling and muscle mass regulation in skeletal muscle of mice exposed to hypoxia Source: Annual Congress 2010 - Interaction between respiratory and peripheral muscles Year: 2010 Effects of inflammation on skeletal muscle Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=68 Year: 2003 Altered muscle metabolism and muscle mass in patients with COPD Source: International Congress 2017 – Neuromuscular consequences of respiratory diseases Year: 2017 Skeletal muscle strength in critical illness Source: Eur Respir J 2005; 26: Suppl. 49, 242s Year: 2005 Decreased expression of genes involved in skeletal muscle oxidative metabolism in COPD patients with muscle wasting Source: Annual Congress 2008 - Respiratory muscle pathophysiology Year: 2008 Effects of electrical muscle stimulation early in the quadriceps and tibialis anterior muscle of critically ill patients Source: Annual Congress 2013 –Exercise and physiotherapy in non-COPD conditions and in the assessment of healthy subjects Year: 2013 Skeletal muscle oxidative capacity is an independent predictor of physical activity in smokers with and without COPD Source: International Congress 2015 – Clinical physiology: mechanisms of symptoms and exercise limitations in health and disease Year: 2015 Assessment of muscle function Source: School Course 2012 - Practical Issues in Pulmonary Rehabilitation Year: 2012